High-risk groups, including children, pregnant individuals, and those over 65, are strongly encouraged to get vaccinated as soon as possible.

Respiratory diseases, such as flu, COVID-19, and RSV, tend to be more prevalent during the fall and winter months.

Historically, influenza infections are low before November and December, making it difficult to predict future trends for the upcoming months.

CDC wastewater tracking indicates low viral levels nationally, although the northeast is currently experiencing the highest levels of respiratory illness.

Individuals can find vaccination locations at vaccine.gov, and the FDA has approved an at-home flu vaccine for those who prefer delivery.

As autumn approaches, health officials are urging the public to prepare for an expected rise in respiratory illnesses, including colds, flus, and COVID-19.

Vaccination remains a crucial strategy, significantly lowering the risk of severe illness, hospitalizations, and long-term complications while also reducing virus transmission.

Currently, seasonal flu activity is low, with no new pediatric flu deaths reported for the 2024-2025 season.

Laboratory testing data is being utilized to monitor the percentage of positive tests for respiratory viruses, which helps indicate infection trends.

The CDC has provided a substantial supply of 148 million flu vaccine doses this year, many of which are preservative-free.

Post-vaccination symptoms, such as muscle aches and fatigue, are normal immune responses as the body builds protection against infections.

While COVID-19 is no longer viewed as an unprecedented crisis, it continues to pose a significant public health issue, particularly for older adults and those with chronic health conditions.